David Anderson
Director/Board Member at CARMELL CORPORATION
Net worth: 14 049 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Randy Hubbell | M | 61 |
Carmell Regen Med Corp.
 Carmell Regen Med Corp. Pharmaceuticals: OtherHealth Technology Carmell Regen Med Corp. develops biomaterials manufactured from blood plasma. It offers biologically-active plastics from blood plasma for treating injuries to bone and connective tissue. The firm focuses on products for the sports medicine market with devices for the repair of tendon and cartilage injuries. It provides REPAIR Bone Putty, a putty form of the plasma-based plastics to fill bone defects; and surgical scaffold for soft tissue repair that heals injured tendons and ligaments. The company was founded by James Edward Burgess, Phil Campbell, and Lee E. Weiss in 2007 and is headquartered in Pittsburgh, PA. | 8 years |
| Joaquin Duato | M | 61 | 35 years | |
| Richard Upton | M | 60 |
Carmell Regen Med Corp.
Carmell Regen Med Corp. Pharmaceuticals: OtherHealth Technology Carmell Regen Med Corp. develops biomaterials manufactured from blood plasma. It offers biologically-active plastics from blood plasma for treating injuries to bone and connective tissue. The firm focuses on products for the sports medicine market with devices for the repair of tendon and cartilage injuries. It provides REPAIR Bone Putty, a putty form of the plasma-based plastics to fill bone defects; and surgical scaffold for soft tissue repair that heals injured tendons and ligaments. The company was founded by James Edward Burgess, Phil Campbell, and Lee E. Weiss in 2007 and is headquartered in Pittsburgh, PA. | 13 years |
| Thomas G. Roueche | M | - |
Fesariustherapeutics, Inc.
 Fesariustherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fesariustherapeutics, Inc. is an American Brooklyn-based company that specializes in tissue repair biomaterial for reconstructive surgeons. The company's flagship product, Dermisphere™, is an intelligently patterned native-state hydrogel scaffold for dermal tissue regeneration. The scaffold is made of collagen microspheres incorporated in a self-assembling collagen hydrogel that provides an optimal environment for cells from surrounding healthy tissues to migrate into the hydrogel. The company was founded by Jason Spector, a renowned plastic surgeon, and has been led by CEO Thomas G. Roueche since 2021. | 3 years |
| Jason Spector | M | - |
Fesariustherapeutics, Inc.
Fesariustherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fesariustherapeutics, Inc. is an American Brooklyn-based company that specializes in tissue repair biomaterial for reconstructive surgeons. The company's flagship product, Dermisphere™, is an intelligently patterned native-state hydrogel scaffold for dermal tissue regeneration. The scaffold is made of collagen microspheres incorporated in a self-assembling collagen hydrogel that provides an optimal environment for cells from surrounding healthy tissues to migrate into the hydrogel. The company was founded by Jason Spector, a renowned plastic surgeon, and has been led by CEO Thomas G. Roueche since 2021. | - |
| Rajiv Sarman Shukla | M | 49 | - | |
| Chuck Hadley | M | - |
Replication Medical, Inc.
 Replication Medical, Inc. Medical SpecialtiesHealth Technology Replication Medical, Inc. develops implantable hydrogel devices. Its products include Enguard, Gelguard, GelFix and GelStix. The company was founded by Vladimir A. Stoy, Chuck G. Hadley and David W. Anderson in 2000 and is headquartered Monmouth Junction, NJ. | 24 years |
| Scott Frisch | M | - | 1 years | |
| Gilles Spenlehauer | M | - | 1 years | |
| Kathryn Gregory | F | 62 | - | |
| David J. McQuillan | M | - |
Fesariustherapeutics, Inc.
Fesariustherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fesariustherapeutics, Inc. is an American Brooklyn-based company that specializes in tissue repair biomaterial for reconstructive surgeons. The company's flagship product, Dermisphere™, is an intelligently patterned native-state hydrogel scaffold for dermal tissue regeneration. The scaffold is made of collagen microspheres incorporated in a self-assembling collagen hydrogel that provides an optimal environment for cells from surrounding healthy tissues to migrate into the hydrogel. The company was founded by Jason Spector, a renowned plastic surgeon, and has been led by CEO Thomas G. Roueche since 2021. | - |
| Terry Wall | M | - |
Brain Temp, Inc.
| - |
| Gabor Forgacs | M | - |
Fesariustherapeutics, Inc.
Fesariustherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fesariustherapeutics, Inc. is an American Brooklyn-based company that specializes in tissue repair biomaterial for reconstructive surgeons. The company's flagship product, Dermisphere™, is an intelligently patterned native-state hydrogel scaffold for dermal tissue regeneration. The scaffold is made of collagen microspheres incorporated in a self-assembling collagen hydrogel that provides an optimal environment for cells from surrounding healthy tissues to migrate into the hydrogel. The company was founded by Jason Spector, a renowned plastic surgeon, and has been led by CEO Thomas G. Roueche since 2021. | - |
| James Hart | M | 72 |
Carmell Regen Med Corp.
Carmell Regen Med Corp. Pharmaceuticals: OtherHealth Technology Carmell Regen Med Corp. develops biomaterials manufactured from blood plasma. It offers biologically-active plastics from blood plasma for treating injuries to bone and connective tissue. The firm focuses on products for the sports medicine market with devices for the repair of tendon and cartilage injuries. It provides REPAIR Bone Putty, a putty form of the plasma-based plastics to fill bone defects; and surgical scaffold for soft tissue repair that heals injured tendons and ligaments. The company was founded by James Edward Burgess, Phil Campbell, and Lee E. Weiss in 2007 and is headquartered in Pittsburgh, PA. | 8 years |
| David Ataide | M | - |
Brain Temp, Inc.
| 6 years |
| Brett S. Spector | M | - |
Fesariustherapeutics, Inc.
Fesariustherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fesariustherapeutics, Inc. is an American Brooklyn-based company that specializes in tissue repair biomaterial for reconstructive surgeons. The company's flagship product, Dermisphere™, is an intelligently patterned native-state hydrogel scaffold for dermal tissue regeneration. The scaffold is made of collagen microspheres incorporated in a self-assembling collagen hydrogel that provides an optimal environment for cells from surrounding healthy tissues to migrate into the hydrogel. The company was founded by Jason Spector, a renowned plastic surgeon, and has been led by CEO Thomas G. Roueche since 2021. | - |
| Patrick Sturgeon | M | 47 | - | |
| William G. Mavity | M | - |
Fesariustherapeutics, Inc.
Fesariustherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fesariustherapeutics, Inc. is an American Brooklyn-based company that specializes in tissue repair biomaterial for reconstructive surgeons. The company's flagship product, Dermisphere™, is an intelligently patterned native-state hydrogel scaffold for dermal tissue regeneration. The scaffold is made of collagen microspheres incorporated in a self-assembling collagen hydrogel that provides an optimal environment for cells from surrounding healthy tissues to migrate into the hydrogel. The company was founded by Jason Spector, a renowned plastic surgeon, and has been led by CEO Thomas G. Roueche since 2021. | - |
| Bryan Cassaday | M | 56 | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael H. Ullmann | M | 66 | 33 years | |
| Gregory Todd Bosch | M | 61 | 8 years | |
| Darren Douglas Weiss | M | 52 | 7 years | |
| Dale Klein | M | 76 |
University of Missouri
| 3 years |
| Mark Z. Schraier | M | - |
University of Missouri
| 7 years |
| Tai-Hong Chin | M | 71 |
University of Missouri
| 8 years |
| Mark Sampson | M | - | 18 years | |
| William E. Fingland | M | - |
University of Missouri
| 5 years |
| Philip Strawbridge | M | 69 |
University of Missouri
| 7 years |
| Jack L. Bowman | M | 91 | 7 years | |
| Shaun Claydon | M | 56 |
Orteq Ltd.
 Orteq Ltd. BiotechnologyHealth Technology Orteq Ltd. develops advanced bioengineering solutions for orthopedic injuries. Its products include actifit, menisci and meniscal injuries and pipeline. The company was founded by David William Anderson and Peter van Wijk in 2005 and is headquartered in London, the United KIngdom. | 5 years |
| Keith Goldan | M | 52 | 4 years | |
| Tom Ebinger | M | 69 |
University of Missouri
| 6 years |
| Noel Rolon | M | - |
Gentis, Inc.
 Gentis, Inc. Medical SpecialtiesHealth Technology Gentis, Inc. engages in the development and testing technologies for the minimally invasive treatments. The company was founded by Charles Cohen and Paul Ducheyne in 2000 and is headquartered in Wayne, PA. | - |
| Daniel Decker | M | 71 |
University of Missouri
| 5 years |
| Peter van Wijk | M | - |
Orteq Ltd.
Orteq Ltd. BiotechnologyHealth Technology Orteq Ltd. develops advanced bioengineering solutions for orthopedic injuries. Its products include actifit, menisci and meniscal injuries and pipeline. The company was founded by David William Anderson and Peter van Wijk in 2005 and is headquartered in London, the United KIngdom. | - |
| Mark Erlander | M | 64 |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | 9 years |
| Tahira Hira | M | 80 |
University of Missouri
| 4 years |
| Jesus Aboud | M | - |
University of Missouri
| 6 years |
| Craig Ault | M | - |
University of Missouri
| 5 years |
| Tom Manion | M | 70 | 8 years | |
| Elizabeth Happe | F | - |
University of Missouri
| 7 years |
| Kenton Zumwalt | M | - |
University of Missouri
| 6 years |
| Mohammed Shahidehpour | M | 68 |
University of Missouri
| 4 years |
| Neil E. Sprague | M | 69 |
University of Missouri
| 8 years |
| Jeffrey O'Donnell | M | 64 |
DSM Biomedical, Inc.
 DSM Biomedical, Inc. Medical SpecialtiesHealth Technology DSM Biomedical, Inc. manufactures and designs medical device materials. The firm's products include bioceramics, polyurethanes, device development, hydrophilic coating solutions, polyethylenes, collagen, and extracellular matrix and drug delivery materials. The company was founded by Kenneth R. Kensey and John E. Nash in 1984 and is headquartered in Exton, PA. | 1 years |
| Robert V. Gahagan | M | - |
University of Missouri
| 8 years |
| David E. Roth | M | - |
University of Missouri
| 4 years |
| John M. Grups | M | 73 |
University of Missouri
| 4 years |
| Kamaroll Zaman bin Abdul Aziz | M | 66 |
University of Missouri
| 4 years |
| Nicholas C. Duane | M | - |
University of Missouri
| 4 years |
| Gerard R. Daignault | M | 65 |
University of Missouri
| 4 years |
| Michael Timothy Moriarty | M | - |
University of Missouri
| 4 years |
| John W. Letzig | M | 70 |
University of Missouri
| 4 years |
| Bob Tucker | M | - |
University of Missouri
| 3 years |
| Rick Means | M | - |
University of Missouri
| 5 years |
| David C. Gobberdiel | M | - |
University of Missouri
| 6 years |
| Jim Beckley | M | - |
University of Missouri
| 4 years |
| David Wilson | M | 69 |
University of Missouri
| 4 years |
| James A. Koch | M | - |
University of Missouri
| 4 years |
| Donald Moody | M | 69 |
University of Missouri
| 4 years |
| Vernon F. Chalfant | M | 68 |
University of Missouri
| 4 years |
| Claire McCaskill | F | 69 |
University of Missouri
| 4 years |
| Mark E. Eck | M | 65 |
University of Missouri
| 4 years |
| James C. Romine | M | - |
University of Missouri
| 4 years |
| Kerri L. Barsh | F | - |
University of Missouri
| 4 years |
| Darrin L. Emerick | M | - |
University of Missouri
| 4 years |
| Chris Lissner | M | - |
University of Missouri
| 4 years |
| Steven W. Fox | M | - |
University of Missouri
| 4 years |
| Andrew Holtgrieve | M | - |
University of Missouri
| 4 years |
| George E. Murray | M | - |
University of Missouri
| 3 years |
| Jennifer Dawson Nicholson | F | 75 |
University of Missouri
| 2 years |
| Ralph Hill | M | 65 |
University of Missouri
| 4 years |
| Mark Joseph Homan | M | - |
University of Missouri
| 4 years |
| Karl A. Dunajcik | M | - |
University of Missouri
| 4 years |
| Todd S. Brown | M | 67 |
University of Missouri
| 2 years |
| Peter William Tuz | M | - |
University of Missouri
| 1 years |
| Julie H. Craven | F | 68 |
University of Missouri
| 1 years |
| Hugh A. Menown | M | 65 |
University of Missouri
| 4 years |
| Thomas Hyde | M | 75 |
University of Missouri
| 3 years |
| Randy Sanderson | M | - |
University of Missouri
| 4 years |
| Michael Brown | M | 67 |
University of Missouri
| 4 years |
| Max S. Barnett | M | - |
University of Missouri
| 4 years |
| Bill Buckner Buckner | M | - |
University of Missouri
| 4 years |
| William L. Allinder | M | - |
University of Missouri
| 3 years |
| Matt Tolksdorf | M | - |
University of Missouri
| 4 years |
| David Lorge | M | 77 |
University of Missouri
| 4 years |
| Gary L. Underwood | M | - |
University of Missouri
| 4 years |
| Fred G. Mcqueary | M | - |
University of Missouri
| 4 years |
| Dan Esser | M | - |
University of Missouri
| 4 years |
| Samuel A. Hamacher | M | - |
University of Missouri
| 4 years |
| Bruce H. Hamory | M | - |
University of Missouri
| - |
| James E. Frey | M | - |
University of Missouri
| 4 years |
| James L. Nouss | M | - |
University of Missouri
| 4 years |
| Larry R. Downey | M | 71 |
University of Missouri
| 4 years |
| Randy Campbell | M | - |
University of Missouri
| 4 years |
| Donald Roberts | M | - |
University of Missouri
| 4 years |
| Eileen Marie Hutchinson | F | - |
University of Missouri
| 4 years |
| Steven B. Rafferty | M | - |
University of Missouri
| 4 years |
| Andres A. Dasso | M | - |
University of Missouri
| 4 years |
| Randy Pace | M | - |
University of Missouri
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 88 | 88.00% |
| United Kingdom | 6 | 6.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David Anderson
- Personal Network